US Bancorp’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.94M | Sell |
6,969
-74
| -1% | -$21.3K | ﹤0.01% | 893 |
|
|
2025
Q4 | $2.13M | Sell |
7,043
-946
| -12% | -$295K | ﹤0.01% | 862 |
|
|
2025
Q3 | $2.24M | Sell |
7,989
-751
| -9% | -$204K | ﹤0.01% | 838 |
|
|
2025
Q2 | $2.11M | Sell |
8,740
-510
| -6% | -$121K | ﹤0.01% | 844 |
|
|
2025
Q1 | $2.25M | Sell |
9,250
-430
| -4% | -$129K | ﹤0.01% | 804 |
|
|
2024
Q4 | $3.18M | Buy |
9,680
+87
| +0.9% | +$29.5K | ﹤0.01% | 710 |
|
|
2024
Q3 | $3.21M | Sell |
9,593
-635
| -6% | -$202K | ﹤0.01% | 704 |
|
|
2024
Q2 | $2.79M | Buy |
10,228
+268
| +3% | +$77.9K | ﹤0.01% | 725 |
|
|
2024
Q1 | $3.44M | Buy |
9,960
+1,209
| +14% | +$398K | ﹤0.01% | 678 |
|
|
2023
Q4 | $2.83M | Sell |
8,751
-629
| -7% | -$197K | ﹤0.01% | 726 |
|
|
2023
Q3 | $3.36M | Buy |
9,380
+2,346
| +33% | +$905K | 0.01% | 638 |
|
|
2023
Q2 | $2.67M | Sell |
7,034
-664
| -9% | -$270K | ﹤0.01% | 707 |
|
|
2023
Q1 | $3.69M | Buy |
7,698
+600
| +8% | +$281K | 0.01% | 623 |
|
|
2022
Q4 | $2.98M | Buy |
7,098
+1,859
| +35% | +$750K | 0.01% | 679 |
|
|
2022
Q3 | $2.19M | Buy |
5,239
+11
| +0.2% | +$5.48K | ﹤0.01% | 748 |
|
|
2022
Q2 | $2.59M | Sell |
5,228
-58
| -1% | -$30.2K | 0.01% | 714 |
|
|
2022
Q1 | $2.98M | Buy |
5,286
+133
| +3% | +$80.2K | 0.01% | 733 |
|
|
2021
Q4 | $3.89M | Sell |
5,153
-53
| -1% | -$39.7K | 0.01% | 662 |
|
|
2021
Q3 | $3.88M | Sell |
5,206
-82
| -2% | -$61.4K | 0.01% | 640 |
|
|
2021
Q2 | $3.41M | Sell |
5,288
-36
| -0.7% | -$21.9K | 0.01% | 694 |
|
|
2021
Q1 | $3.04M | Buy |
5,324
+80
| +2% | +$47.4K | 0.01% | 695 |
|
|
2020
Q4 | $3.06M | Buy |
5,244
+68
| +1% | +$38.7K | 0.01% | 667 |
|
|
2020
Q3 | $2.67M | Buy |
5,176
+12
| +0.2% | +$6.08K | 0.01% | 652 |
|
|
2020
Q2 | $2.33M | Buy |
5,164
+44
| +0.9% | +$19.4K | 0.01% | 681 |
|
|
2020
Q1 | $1.79M | Buy |
5,120
+416
| +9% | +$153K | 0.01% | 702 |
|
|
2019
Q4 | $1.74M | Sell |
4,704
-5
| -0.1% | -$1.76K | ﹤0.01% | 825 |
|
|
2019
Q3 | $1.57M | Buy |
4,709
+465
| +11% | +$152K | ﹤0.01% | 851 |
|
|
2019
Q2 | $1.33M | Sell |
4,244
-41
| -1% | -$12.3K | ﹤0.01% | 953 |
|
|
2019
Q1 | $1.31M | Sell |
4,285
-71
| -2% | -$19.2K | ﹤0.01% | 951 |
|
|
2018
Q4 | $1.01M | Sell |
4,356
-109
| -2% | -$29.2K | ﹤0.01% | 1004 |
|
|
2018
Q3 | $1.4M | Buy |
4,465
+123
| +3% | +$38.2K | ﹤0.01% | 947 |
|
|
2018
Q2 | $1.25M | Sell |
4,342
-110
| -2% | -$30.4K | ﹤0.01% | 998 |
|
|
2018
Q1 | $1.11M | Buy |
4,452
+75
| +2% | +$19.1K | ﹤0.01% | 1034 |
|
|
2017
Q4 | $1.04M | Buy |
4,377
+109
| +3% | +$26.4K | ﹤0.01% | 1081 |
|
|
2017
Q3 | $949K | Buy |
4,268
+44
| +1% | +$9.9K | ﹤0.01% | 1109 |
|
|
2017
Q2 | $956K | Buy |
4,224
+34
| +0.8% | +$7.41K | ﹤0.01% | 1077 |
|
|
2017
Q1 | $835K | Buy |
4,190
+186
| +5% | +$35.8K | ﹤0.01% | 1160 |
|
|
2016
Q4 | $730K | Buy |
4,004
+93
| +2% | +$15.9K | ﹤0.01% | 1208 |
|
|
2016
Q3 | $641K | Buy |
3,911
+63
| +2% | +$9.56K | ﹤0.01% | 1242 |
|
|
2016
Q2 | $550K | Sell |
3,848
-294
| -7% | -$41.9K | ﹤0.01% | 1280 |
|
|
2016
Q1 | $566K | Sell |
4,142
-99
| -2% | -$13K | ﹤0.01% | 1239 |
|
|
2015
Q4 | $588K | Sell |
4,241
-345
| -8% | -$47.8K | ﹤0.01% | 1233 |
|
|
2015
Q3 | $615K | Buy |
4,586
+140
| +3% | +$20.1K | ﹤0.01% | 1204 |
|
|
2015
Q2 | $670K | Buy |
4,446
+817
| +23% | +$117K | ﹤0.01% | 1210 |
|
|
2015
Q1 | $490K | Sell |
3,629
-4
| -0.1% | -$496 | ﹤0.01% | 1366 |
|
|
2014
Q4 | $438K | Buy |
3,633
+38
| +1% | +$4.37K | ﹤0.01% | 1396 |
|
|
2014
Q3 | $408K | Sell |
3,595
-368
| -9% | -$43.6K | ﹤0.01% | 1421 |
|
|
2014
Q2 | $474K | Buy |
3,963
+136
| +4% | +$16.6K | ﹤0.01% | 1384 |
|
|
2014
Q1 | $490K | Sell |
3,827
-73
| -2% | -$9.36K | ﹤0.01% | 1341 |
|
|
2013
Q4 | $482K | Sell |
3,900
-325
| -8% | -$39.6K | ﹤0.01% | 1320 |
|
|
2013
Q3 | $497K | Sell |
4,225
-191
| -4% | -$22.5K | ﹤0.01% | 1240 |
|
|
2013
Q2 | $495K | Buy |
+4,416
| New | +$518K | ﹤0.01% | 1184 |
|
Other funds holding BIO
VCM
VPM
AI
